Medtronic 2014 Annual Report Download - page 16

Gastroenterology & Urology Systems. Sacral neuromodulation uses InterStim, a neurostimulator, to help control the
symptoms of overactive bladder, (non-obstructive) urinary retention, and chronic fecal incontinence. The InterStim system
consists of a thin wire lead and a neurostimulator. After a successful trial stimulation period, the system is implanted under the
skin in the upper buttock and delivers mild electrical pulses to stimulate the sacral nerves, which are involved in the control of
bladder and bowel function. Enterra Therapy is the only gastric electrical stimulation therapy approved in the U.S. (under a
HDE), Europe, and Canada for use in the treatment of intractable nausea and vomiting associated with gastroparesis. The
system, which contains a small neurostimulator and two leads, stimulates the smooth muscles of the lower stomach.
The charts below set forth net sales of our Neuromodulation products as a percentage of our total net sales for each of the last
three fiscal years:
Fiscal Year 2012
(dollars in millions)
Neuromodulation
$1,700
All Other
$14,484
Fiscal Year 2013
(dollars in millions)
All Other
$14,778
Neuromodulation
$1,812
Fiscal Year 2014
(dollars in millions)
All Other
$15,107
Neuromodulation
$1,898
11%
89%
11%
89%
11%
89%
Customers and Competitors
The primary medical specialists who use our pain management and movement disorder products are neurosurgeons,
neurologists, pain management specialists, anesthesiologists, physiatrists, and spinal surgeons. Our primary competitors in this
business are Boston Scientific and St. Jude.
The primary medical specialists who use our gastroenterology and urology products are urologists, urogynecologists,
gastroenterologists, and colorectal surgeons. Our primary competitors in this business are Allergan, Inc., Uroplasty, Inc., and
Astellas Pharma, Inc.
Surgical Technologies
Our Surgical Technologies business develops, manufactures, and markets products and therapies to treat diseases and conditions
of the ear, nose, and throat (ENT) and certain neurological disorders. In addition, the business develops, manufactures, and
markets image-guided surgery and intra-operative imaging systems that facilitate surgical planning during precision cranial,
spinal, sinus, and orthopedic surgeries. Our Advanced Energy business includes products in the emerging field of advanced
energy surgical incision technology, as well as the haemostatic sealing of soft tissue and bone.
The following are the principal products offered by our Surgical Technologies business:
Neurosurgery. The following products treat certain neurological disorders and conditions: Midas Rex Spine Shaver, the
Midas Rex MR7 Pneumatic Platform, the Midas Rex Legend EHS High Speed Surgical Drill, the Strata Family of Adjustable
Valves for the treatment of Hydrocephalus, Duet External Drainage & Monitoring System, the IPC System, and the Subdural
Evacuating Port System. The following Navigation products are used in cranial, spinal, sinus, and orthopedic surgeries: the
StealthStation S7 Navigation and i7 Integrated Navigation Systems, the O-arm 2D/3D Surgical Imaging System, and the
Polestar Surgical MRI System.
ENT. The following products treat ENT diseases and conditions: Straightshot M4 Microdebrider Handpiece, the IPC system,
NIM Nerve Monitoring Systems, Fusion ENT Navigation System, Hydrodebrider Endoscopic Sinus Irrigation System, Meniett
Device for Meniere’s Disease, as well as surgical products for Snoring and Obstructive Sleep Apnea.
Advanced Energy. Our PEAK Surgery System is a tissue dissection system that consists of the PEAK PlasmaBlade and
PULSAR Generator and is cleared for use in a variety of settings, including plastic reconstructive, general surgery, and
8